Neurocrine Biosciences Inc (NASDAQ:NBIX)
| 98.23 Delayed Data As of Jun 24 |  +0.83 / +0.85%Today’s Change | 71.88 Today|||52-Week Range 108.02 | +15.33% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Gano Kyle W Chief Business Development Officer |  Sale | 1/05/2022 | 28,266 | $85.50 | $2.4M | +18.01% |
Lloyd-smith Malcolm C Chief Regulatory Officer | Sale | 7/27/2021 | 16,709 | $93.80 | $1.6M | +4.40% |
Lyons Gary A Director | Sale | 4/25/2022 | 15,000 | $92.76 | $1.4M | +4.78% |
Sherwin Stephen A Director | Sale | 1/24/2022 | 15,000 | $74.43 | $1.1M | +29.50% |
Rastetter William H Director | Sale | 4/01/2022 | 10,728 | $94.93 | $1.0M | +2.79% |
Lippoldt Darin M Chief Legal Officer | Sale | 3/22/2022 | 8,455 | $95.05 | $803.6K | +3.62% |
Pops Richard F Director | Sale | 5/09/2022 | 7,500 | $76.30 | $572.3K | +29.62% |
Pops Richard F Director | Sale | 5/09/2022 | 7,500 | $76.29 | $572.2K | +29.62% |
Lyons Gary A Director | Sale | 10/07/2021 | 5,000 | $105.06 | $525.3K | -4.66% |
Grigoriadis Dimitri E Chief Research Officer | Sale | 10/07/2021 | 5,000 | $104.85 | $524.3K | -4.66% |
Page of 6